Aplicability Of The Predictive Model Of Response To Erythropoetic Stimulating Agents (ESA) From Myelodysplastic Syndromes (MDS) and Analysis Of Response and Overall Survival (OS) In a Series Of 99 Patients (Pts) With Chronic Myelomonocytic Leukemia (CMML) From The Spanish Registry Of MDS and The Düsseldorf-MDS Registry, Germany

Bibliographic Details
Title:	Aplicability Of The Predictive Model Of Response To Erythropoetic Stimulating Agents (ESA) From Myelodysplastic Syndromes (MDS) and Analysis Of Response and Overall Survival (OS) In a Series Of 99 Patients (Pts) With Chronic Myelomonocytic Leukemia (CMML) From The Spanish Registry Of MDS and The Düsseldorf-MDS Registry, Germany
Authors:	Xicoy, Blanca ^, Germing, Ulrich ^, Jimenez, Maria-Jose ^, García, Regina ^, Garcia, Olga ^, Pedro, Carme ^, Schemenau, Jennifer ^, Luño, Elisa ^, Medina, Angeles ^, Bernal, Teresa ^, Neukirchen, Judith ^, Gonzalez, Bernardo ^, Maria-Teresa, Ardanaz ^, Kündgen, Andrea ^, Cedena, Teresa ^, Tormo, Mar, Brunet, Salut ^, Valcarcel, David ^, Amigo, Luz ^, Vicente, Ana ^, Ramos, Fernando ^, Marta, Callejas ^, Arilla, Maria-Jesus ^, Diez-Campelo, Maria ^, Bailen, Alicia ^, Collado, Rosa ^, Arnan, Montserrat ^, Marco, Victor ^, Zamora, Lurdes ^, Allegue, Maria-Jose ^, Benlloch, Luis ^, Sanz, Guillermo
Source:	In Blood 15 November 2013 122(21):2813-2813
Database:	ScienceDirect